Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial
Clinical trial NCT05142241 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05142241
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-11
- Primary completion
- 2025-09-26
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.